Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit.

Publikation: Bidrag til tidsskriftTidsskriftartikel

Harvard

APA

CBE

MLA

Vancouver

Author

Balslev, Ulla ; Bremmelgaard, Annie ; Svejgaard, E ; Havstreym, Jeannette ; Westh, Henrik. / An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit. I: Microbial Drug Resistance. 2005 ; Bind 11, Nr. 1. s. 78-81.

Bibtex

@article{5ebd5ff05bd746ca8749882e871b65a2,
title = "An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit.",
abstract = "From February through July, 2000, there was an accumulation of mecA-negative borderline resistant Staphylococcus aureus (BORSA) in the Department of Dermatology. BORSA was isolated in 37 samples from 11 patients. The isolates were typed by antibiogram, phage type, pulsed-field gel electrophoresis (PFGE), and spa genotyping that confirmed that they were indistinguishable from one another. In May, 2000, an intervention was initiated focusing on infection control. In-patients with BORSA were discharged and antibiotic treatment was stopped, if possible. Emphasis was put on disinfection of shared utensils and individualization of previously shared creams and lotions. After the intervention, BORSA was isolated from another 3 patients before the outbreak was terminated. A case-control study was undertaken to identify possible risk factors for being a BORSA patient. Compared to the controls, the patients with BORSA had more severe skin disease, were more often hospitalized, and had more bed days.",
author = "Ulla Balslev and Annie Bremmelgaard and E Svejgaard and Jeannette Havstreym and Henrik Westh",
year = "2005",
language = "English",
volume = "11",
pages = "78--81",
journal = "Microbial Drug Resistance",
issn = "1076-6294",
publisher = "Mary Ann/Liebert, Inc. Publishers",
number = "1",

}

RIS

TY - JOUR

T1 - An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit.

AU - Balslev, Ulla

AU - Bremmelgaard, Annie

AU - Svejgaard, E

AU - Havstreym, Jeannette

AU - Westh, Henrik

PY - 2005

Y1 - 2005

N2 - From February through July, 2000, there was an accumulation of mecA-negative borderline resistant Staphylococcus aureus (BORSA) in the Department of Dermatology. BORSA was isolated in 37 samples from 11 patients. The isolates were typed by antibiogram, phage type, pulsed-field gel electrophoresis (PFGE), and spa genotyping that confirmed that they were indistinguishable from one another. In May, 2000, an intervention was initiated focusing on infection control. In-patients with BORSA were discharged and antibiotic treatment was stopped, if possible. Emphasis was put on disinfection of shared utensils and individualization of previously shared creams and lotions. After the intervention, BORSA was isolated from another 3 patients before the outbreak was terminated. A case-control study was undertaken to identify possible risk factors for being a BORSA patient. Compared to the controls, the patients with BORSA had more severe skin disease, were more often hospitalized, and had more bed days.

AB - From February through July, 2000, there was an accumulation of mecA-negative borderline resistant Staphylococcus aureus (BORSA) in the Department of Dermatology. BORSA was isolated in 37 samples from 11 patients. The isolates were typed by antibiogram, phage type, pulsed-field gel electrophoresis (PFGE), and spa genotyping that confirmed that they were indistinguishable from one another. In May, 2000, an intervention was initiated focusing on infection control. In-patients with BORSA were discharged and antibiotic treatment was stopped, if possible. Emphasis was put on disinfection of shared utensils and individualization of previously shared creams and lotions. After the intervention, BORSA was isolated from another 3 patients before the outbreak was terminated. A case-control study was undertaken to identify possible risk factors for being a BORSA patient. Compared to the controls, the patients with BORSA had more severe skin disease, were more often hospitalized, and had more bed days.

M3 - Journal article

VL - 11

SP - 78

EP - 81

JO - Microbial Drug Resistance

JF - Microbial Drug Resistance

SN - 1076-6294

IS - 1

ER -

ID: 32502342